Biological monitoring of butadiene exposure by measurement of haemoglobin adducts

被引:13
作者
Richardson, KA [1 ]
Megens, HJJJ [1 ]
Webb, JD [1 ]
vanSittert, NJ [1 ]
机构
[1] SHELL RES LTD,SITTINGBOURNE RES CTR,SITTINGBOURNE ME9 8AG,KENT,ENGLAND
关键词
butadiene; biomonitoring haemoglobin; adducts; Edman degradation;
D O I
10.1016/0300-483X(96)03435-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The measurement of haemoglobin (Hb) adducts is an important tool for monitoring exposures to industrial chemicals such as ethylene, ethylene oxide and propylene oxide. The aim of the present study was to use this method to monitor occupational exposure to butadiene. The methodology was evaluated with Hb samples obtained by reacting butadiene monoepoxide (BkO), the primary reactive metabolite of 1,3-butadiene, with blood and by dosing BMO to rats and mice. The Hb adducts: N-(2-hydroxy-3-buten-1-yl)valine and N-(1-hydroxy-3-buten-2-yl)valine were determined as the pentafluorophenylthiohydantoin derivatives using the modified Edman degradation procedure and gas chromatography with negative ion chemical ionisation mass spectrometry. The adducts were quantified using d(4)-N-(2-hydroxyethyl)valine as an internal reference chemical. Relatively high background signals were observed which made accurate quantitation difficult, The lower limit of detection was estimated as 10-20 pmol/g globin, The experiments have demonstrated that appropriate reference samples are required for accurate quantitation and the method requires further refinement to improve the sensitivity of the analysis.
引用
收藏
页码:112 / 118
页数:7
相关论文
共 5 条
[1]   INTRINSIC REACTIVITIES IN THE ALKYLATIONS OF PROTECTED AMINO-ACIDS BY (R)-METHYLOXIRANE AND (S)-METHYLOXIRANE [J].
ELLIS, MK ;
GOLDING, BT ;
WATSON, WP .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1984, (11) :1737-1743
[2]   HEMOGLOBIN ADDUCTS AND URINARY MERCAPTURIC ACIDS IN RATS AS BIOLOGICAL INDICATORS OF BUTADIENE EXPOSURE [J].
OSTERMANGOLKAR, S ;
KAUTIAINEN, A ;
BERGMARK, E ;
HAKANSSON, K ;
MAKIPAAKKANEN, J .
CHEMICO-BIOLOGICAL INTERACTIONS, 1991, 80 (03) :291-302
[3]  
OSTERMANGOLKAR SM, 1993, IARC SCI PUBL, V127, P127
[4]  
TORNQVIST M, 1986, ANAL BIOCHEM, V154, P255, DOI 10.1016/0003-2697(86)90524-5
[5]  
Van Sittert Nico J., 1994, Clinical Chemistry, V40, P1472